Polymorphs, Salts, Cocrystals, Amorphous Forms — Identify the Optimal Physical Form for Your API with Expert Guidance.
Get a Consultation
Polymorphs, Salts, Cocrystals, Amorphous Forms — Identify the Optimal Physical Form for Your API with Expert Guidance.
Get a ConsultationPharmaFormFinders specializes in solid-state chemistry and helps pharmaceutical companies identify the optimal physical form of their drug substance. Whether it’s screening for polymorphs, salts.
Discover the most developable and stable form of your API with comprehensive solid-form exploration.
Gain clarity on your molecule’s stability profile with data-driven solid-state interpretation.
Resolve complex formulation and processing issues with targeted solid-state problem-solving.
From complex polymorph challenges to crystal-form IP strategy, PharmaFormFinders delivers science-backed solutions that help your molecule move forward with confidence.
Speak With an Expert
Helping R&D teams identify optimal forms (polymorphs, salts, cocrystals, amorphous) to unlock better drug performance.
Assisting with crystal-form patents, claim structures, and stability-focused form identification.
Providing expert oversight for screening, characterization, and stability assessments.
Ensuring stability, manufacturability, flow properties, dissolution improvement, and seamless scale-up.
Managing morphology, stability, and transition risks to support consistent large-scale manufacturing.
Offering guidance on optimal physical forms to avoid costly delays in early development stages.
Location : London - UK
A European biotech developing a new cocrystal-based drug candidate required guidance for intellectual property protection.
Read More
Location : Colorado - USA
A biotech startup developing a promising oncology API approached PharmaFormFinders after facing inconsistencies in dissolution performance.
Read More
His understanding of polymorphic behavior and crystal form control resolved months of instability issues.
Fill out the form below, and we’ll schedule a consultation to discuss your solid-state challenges.
